Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy

M. Diakopoulou, O. Brodin, K. G. Kolbeck (Stockholm, Sweden)

Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Session: Diagnosis of thoracic malignancies
Session type: Thematic Poster Session
Number: 3871
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Diakopoulou, O. Brodin, K. G. Kolbeck (Stockholm, Sweden). Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy. Eur Respir J 2007; 30: Suppl. 51, 3871

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Comparison of integrated PET-CT remediastinoscopy to restage IIIA-N2 NSCLC after induction chemotherapy
Source: ISSN=ISSN 1810-6838, ISBN=, page=289
Year: 2007

Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009

FDG-PET is superior to conventional CT in predicting histologic responses after induction therapy for locally advanced NSCLC
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010

Indcution chemotherapy and radiotherapy vs. induction and simultaneous radiochemotherapy in inoperable stage III NSCLC. Update on BROCAT study CTRT 99/97
Source: Eur Respir J 2006; 28: Suppl. 50, 833s
Year: 2006

Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC.
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020

Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003

Chemotherapy plus resection is not better than chemoradiotherapy for baseline unresectable stage IIIA-N2 NSCLC
Source: ISSN=ISSN 1810-6838, ISBN=, page=380
Year: 2007

PET-CT, NSCLC staging and surgery: an audit of current experience
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008

Modern radiotherapy as a curative treatment modality for stage III NSCLC
Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease
Year: 2019

Surgery for nonsmall cell lung cancer: can improvements be made?
Source: Eur Respir J 2003; 21: 52S-56S
Year: 2003

Efficacy of induction chemotherapy and following simultaneous radiochemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (Stage IIIA/IIIB): update of CT/RT 99/97
Source: Annual Congress 2004 - Management of lung cancer and innovative therapies
Year: 2004

Induction chemotherapy and simultaneous radiochemotherapy or radiotherapy in inoperable NSCLC (stage IIIA/IIIB)
Source: Eur Respir J 2002; 20: Suppl. 38, 399s
Year: 2002

Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006

The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005

Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC
Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology
Year: 2012

Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021

Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449)
Source: International Congress 2017 – Interventional pulmonology highlights 2017
Year: 2017